BMRN

#761
BioMarin Pharmaceutical Inc. - Common Stock
57.2 9 USD
+8.77%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
57.29
57.29
Range Annuel
49.26
66.28
Changement quotidien
+8.77%
Changement Mensuel
+5.60%
Evolution sur 6 mois
+3.23%
Changement Annuel
-2.02%
Clôture Précédente
52.6 7
Open
57.2 9
Low
57.2 9
High
57.2 9
Volume
194
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

BioMarin Pharmaceutical Inc. - Common Stock

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Nouvelles